Brind.

BioTime developed a GMP banking and production platform and provides clinical/development expertise involving Genentech and Roche.

1 report, 1 independent Updated Aug 13

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

BioTime Hoffmann-La Roche

Keep exploring

The entities involved

BioTime
company

Nothing else this week.
Hoffmann-La Roche
Swiss healthcare company
- Hoffmann-La Roche signed a cooperation program with the Iraqi Ministry of Health to provide medical care in Iraq.Sat 05:44
- FDA approved a GSK drug and authorized a Roche blood test for eligibility, amidst estimates of 1.7M chronic HBV patients in the US.Fri 12:54

Coverage

Newest first; wire copies grouped

Aug 13GuruFocus.comLineage Cell Therapeutics Inc (LCTX) Q2 2025 Earnings Call Highlights: Strategic Partnerships ... Release Date: August 12, 2025 For the complete transcript of the earnings call, please refer to the f